BRCA2 Blue: Rad51; Green: BRCA2 www.oncology.cam.ac.uk/Venkitaraman.html.

Slides:



Advertisements
Similar presentations
What is Li-Fraumeni syndrome?
Advertisements

TSC2 and Tuberous Sclerosis Complex Disease Laura Koontz Biology 169.
By Janet Soper and its Effects in Breast Cancer and Ovarian Cancer.
HNPCC and MLH1 Qi Peng Cancer Biology March 30 th, 2006.
P53 gene mutations in human tumors Greenblatt et al. (1995) Cancer Res. 54: %
BRCA1 Breast Cancer 1, Early Onset Simple gene, or breast/ovarian cancer’s best friend? By:Courtney Abshier.
Transforming Growth Factor β Receptor Type II Tina Morris
Phosphatase and Tensin Homolog Deleted on Chromosome 10
MDM2: Oncogene Chan Lee. Discovery of MDM2: starting with tumor suppressor p53.
P53 gene mutations in human tumors Greenblatt et al. (1995) Cancer Res. 54: %
BRCA1 The First Breast Cancer Gene Presentation By Liz Mosley.
BRCA Genes Dallas Henson.
BRCA Mutations and Breast Cancer Ruth Phillips and Patty Ashby.
The Cancer Pedigree BRCA What?. Outline Introduction: Understanding the weight of genetics in Ovarian Breast Cancer BRCA 1 and BRCA 2 Genes – Function.
Cancer Estimated US Cancer Cases Cancer Incidence Rates for Women, USA.
BRCA2 Clark Cunningham March 26, 2015 BIOL445 American Cancer Society, eastcancer/make-a-pink-ribbon-lapel-pin,
Ovarian Cancer Risk Reduction Taking oral contraceptives for 5 years can reduce your risk of ovarian cancer by up to 50% Hankinson SE, Colditz GA, Hunter.
Tumor Suppressors Versus Oncogenes. The Cancer Phenotype is Usually Recessive R. Weinberg, Cancer Biology.
BRCA1 and Breast Cancer Madeline Ryan 3/17/2015.
BRCA1: Tumor Suppression and Breast Cancer A breast cancer cell dividing.
Problem 1 James is the only person in his kindred affected by DMD. He has one unaffected brother, Joe. DNA analysis show that James has a deletion in the.
P57, Tumorigenesis, and Beckwith-Wiedemann Syndrome Ashley Albright.
Breast Ovarian Hereditary Breast & Ovarian Cancer Knowing one’s family medical history can be life-saving.
Breast Cancer and BRCA2. 1 million women worldwide diagnosed. 1 out of 12 women in Western Europe and the United States 30% mortality rate Highest cause.
BRG-1 in Cancer BRG-1 is an ATPase subunit of the SWI/SNF class of chromatin remodeling complexes It has been found mutated in a number of cancer cell.
Do Now If a diploid pea plant has one copy of a gene (allele) for green seed color, and one copy for yellow, what is the probability it will produce a.
Lecture 28 Genetics of Cancer Copyright © 2010 Pearson Education Inc.
BRCA2: Breast Cancer Susceptibility Gene 2 Lindy Behrend March 4, 2003.
Javad Jamshidi Fasa University of Medical Sciences, December 2015 Cancer Genetics Session 4 Medical Genetics.
Regulating the Cell Cycle the cell cycle has a built-in genetic signals to tell cells when to start and stop dividing –proto-onco genes – genes that encourage.
TSC1 and Facial Angiofibromas
Tumor Suppressors Versus Oncogenes. Retinoblastoma is a Cancerous Disease Hereditary childhood cancer: bilateral tumors in 25-30% of cases unilateral.
Cancer Chapter 4 Supplement. Cancer - important facts Cancer is uncontrolled cell growth It requires several steps to form It is very different depending.
Natasha Adlakha Bio445. Discovery in Breast Cancer Reverse Genetics BReast CAncer Gene Chromosome 13 Tumor suppressor gene Penetrance Familial,
Tumor Suppressor Gene Involved in Breast and Ovarian Cancers SCIENCE96/gene.cgi?BRCA1.
TSC1/Hamartin and Facial Angiofibromas Biology 169 Ann Hau.
Cancer. Cancer is a disease of the cell cycle Caused by one or more of the following: Increase in growth signals Loss of inhibitory signals In addition,
HCDC4 & Endometrial Carcinoma Diana Rhyne. hCDC4 – Gene Information  Homologs in S. cervisiae, Drosophilia, and C. elegans  Tumor Suppressor  Expressed.
c-Myc A Biological Paradox
THE GENETIC BASIS OF CANCER
Karyotyping Cancer.
Mouse Double Minute 2 (MDM2)
Fostering a Collaborative Approach in the Management of BRCA-Mutated Ovarian Cancer.
Figure 1. (A) Cumulative risk of breast (diamonds) and ovarian (squares) cancer in BRCA1 mutation carriers. (B) Cumulative risk of breast (diamonds) and.
Family Tree Presentation
The Role of SMAD4 (DPC4) in Cancer
breast cancer 2, early onsetpro What does this protein make up or do?
BRCA1 Breast Cancer.
Microarray analysis each spot represents one gene Yellow: no change in
Fibroblast Growth Factor 3 (FGF3) int-2
Genomic Instability and Cancer
B lymphocytes produce antibodies.
Mutations and Genetic Abnormalities
PTEN (a.k.a. MMAC1 and TEP1) and Cowden’s Disease
Counseling Patients About Germline BRCA Mutations
Events of The Cell Division Cycle Occur in a Particular Order
BIOLOGY 12 Cancer.
Genomic alterations in breast cancer cell line MDA-MB-231.
PTEN Tumor Suppressor and Cancer
HER2 mutants V777L, G309A, D769H formed tumors more rapidly than HER2 WT. A, a total of 0.5 × 106 cells of NIH3T3 expressing either HER2 WT or mutant were.
The decision tree with the two alternatives.
History of DNA.
Specific Tumor Suppressor Genes
Biology of hereditary breast and ovarian cancer (HBOC)
by Jennifer Couzin-Frankel
Giovanni Parmigiani, Donald A. Berry, Omar Aguilar 
Changes in tumor sizes, CA-125, serum ceruloplasmin, and copper levels in 5 patients with platinum-resistant high-grade epithelial ovarian cancer who received.
Kaplan-Meier survival analysis of p53 mutation in the overall breast tumor series. Kaplan-Meier survival analysis of p53 mutation in the overall breast.
p53 loss affects several steps of the metastatic process.
Single nucleotide polymorphism array analysis can distinguish different genetic mechanisms that lead to loss of heterozygosity (LOH). Single nucleotide.
Presentation transcript:

BRCA2 Blue: Rad51; Green: BRCA2

Statistics 1/8 women will get breast cancer 80% have no family history of cancer 20% has a family member with some germline history of cancer 50% are caused by a mutation in either BRCA1 or BRCA2 Notes: - Risk developing cancer averages about 13% with a BRCA2 mutation about 60-80% - Risk of developing ovarian cancer 1.5% with a BRCA2 mutation about 15-27% -About 70 to 80% of all familial ovarian cancers are due to mutant germline alleles of BRCA1 and 2

What process is BRCA2 involved? BRCA2 and Rad51 increased levels of expression During S phase of cell cycle Induce mutations in Drosophila to see what process BRCA2 is involved in. homepage.mac.com/enognog/cell%20cycle.jpg

Homologous Recombination Sung, P. et al. J. Biol. Chem. 2003;278:

Rad51 Sung, P. et al. J. Biol. Chem. 2003;278:

Rad51 Nature Genetics 27, (2001)

BRCA2 Narod, Nature Reviews: Cancer (2004)

BRCA2 Powell, Oncogene (2003)

BRCA2 CREDIT: H. YANG ET AL., SCIENCE 297, 1837 (13 SEPTEMBER 2002)

Tumor Suppressor

Knockout Mice Knockout BRCA2 genes give a lethal phenotype. R. Weinberg, Cancer Biology BRCA2 requires 2 mutant copies to have the ability for the mouse to develop a tumor.

How BRCA2 Causes Cancer Nature Genetics 27, (2001)